Dr Nandor Marczin

Publications


Journals

  • Zych B; Popov AF; Stavri G; Bashford A; Bahrami T; Amrani M; De Robertis F; Carby M; et alMarczin N; Simon AR; Redmond KC. (14 Nov 2011). Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. J Heart Lung Transplant. DOI.
  • Potapov E; Meyer D; Swaminathan M; Ramsay M; El Banayosy A; Diehl C; Veynovich B; Gregoric ID; et alKukucka M; Gromann TW; Marczin N; Chittuluru K; Baldassarre JS; Zucker MJ; Hetzer R. (Aug 2011). Inhaled nitric oxide after left ventricular assist device implantation: A prospective, randomized, double-blind, multicenter, placebo-controlled trial. J HEART LUNG TRANSPL. 30:870-878. DOI.
  • Korovesi I; Papadomichelakis E; Orfanos SE; Giamarellos-Bourboulis EJ; Livaditi O; Pelekanou A; Sotiropoulou C; Koutsoukou A; et alDimopoulou I; Ekonomidou F; Psevdi E; Armaganidis A; Roussos C; Marczin N; Kotanidou A. (May 2011). Exhaled breath condensate in mechanically ventilated brain-injured patients with no lung injury or sepsis. Anesthesiology. 114:1118-1129. DOI.
  • Boshier PR; Priest OH; Hanna GB; Marczin N. (Oct 2011). Influence of respiratory variables on the on-line detection of exhaled trace gases by PTR-MS. Thorax. 66:919-920. DOI.
  • Bertok S; Wilson MR; Dorr AD; Dokpesi JO; O'Dea KP; Marczin N; Takata M. (May 2011). Characterization of TNF receptor subtype expression and signaling on pulmonary endothelial cells in mice. Am J Physiol Lung Cell Mol Physiol. 300:L781-L789. DOI.
  • Varga T; Kovesi T; Gal J; Marczin N. (Sep 2010). Endogenous and nitrovasodilator-induced release of NO in the airways of end-stage cystic fibrosis patients. EUR RESPIR J. 36:682-683. DOI.
  • Boshier PR; Cushnir JR; Priest OH; Marczin N; Hanna GB. (Sep 2010). Variation in the levels of volatile trace gases within three hospital environments: implications for clinical breath testing. J BREATH RES. 4. DOI.
  • Boshier PR; Marczin N; Hanna GB. (Jun 2010). Repeatability of the measurement of exhaled volatile metabolites using selected ion flow tube mass spectrometry. J Am Soc Mass Spectrom. 21:1070-1074. DOI.
  • Gal J; Kovesi T; Royston D; Marczin N. (Dec 2007). Dynamics of nitroglycerin-induced exhaled nitric oxide after lung transplantation: evidence of pulmonary microvascular injury?. J Heart Lung Transplant. 26:1300-1305. DOI.
  • Farkasfalvi K; Stagg MA; Coppen SR; Siedlecka U; Lee J; Soppa GK; Marczin N; Szokodi I; et alYacoub MH; Terracciano CM. (15 Jun 2007). Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem Biophys Res Commun. 357:889-895. DOI.
  • Hoare GS; Birks EJ; Bowles C; Marczin N; Yacoub MH. (Nov 2006). In vitro endothelial cell activation and inflammatory responses in end-stage heart failure. J Appl Physiol. 101:1466-1473. DOI.
  • Kövesi T; Szabo A; Royston D; Marczin N. (Dec 2005). Correlation between pulmonary gas exchange and basal and nitroglycerin (GTN)-induced exhaled nitric oxide (eNO) in patients undergoing cardiac surgery. Vascul Pharmacol. 43:434-440. DOI.
  • Marczin N. (Dec 2005). Exhaled NO as a biological marker of lung inflammation: Airways and beyond. VASC PHARMACOL. 43:369-370. DOI.
  • Marczin N. (Dec 2005). The biology of exhaled nitric oxide (NO) in ischemia-reperfusion-induced lung injury: a tale of dynamism of NO production and consumption. Vascul Pharmacol. 43:415-424. DOI.
  • Germann P; Braschi A; Della Rocca G; Dinh-Xuan AT; Falke K; Frostell C; Gustafsson LE; Herve P; et alJolliet P; Kaisers U; Litvan H; Macrae DJ; Maggiorini M; Marczin N; Mueller B; Payen D; Ranucci M; Schranz D; Zimmermann R; Ullrich R. (Aug 2005). Inhaled nitric oxide therapy in adults: European expert recommendations. INTENS CARE MED. 31:1029-1041. DOI.
  • Ghosh S; Wilson MR; Choudhury S; Yamamoto H; Goddard ME; Falusi B; Marczin N; Takata M. (Jun 2005). Effects of inhaled carbon monoxide on acute lung injury in mice. Am J Physiol Lung Cell Mol Physiol. 288:L1003-L1009. DOI.
  • Bundy RE; Hoare GS; Kite A; Beach J; Yacoub M; Marczin N. (Jan 2005). Redox regulation of p38 MAPK activation and expression of ICAM-1 and heme oxygenase-1 in human alveolar epithelial (A549) cells. Antioxid Redox Signal. 7:14-24. DOI.
  • Marczin N. (Nov 2004). Tiny wonders of tiny impurities of nitrous oxide during anaesthesia. BRIT J ANAESTH. 93:619-623. DOI.
  • Marczin N; El-Habashi N; Hoare GS; Bundy RE; Yacoub M. (15 Dec 2003). Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms. Arch Biochem Biophys. 420:222-236.
  • Marczin N. (Nov 2003). Exhaled nitric oxide and cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg. 126:1673-1674.
  • Marczin N; El-Habashi N; Royston D. (Jul 2003). Free radicals and cardiac arrhythmias following coronary surgery: actors of the drama or bystanders of the spectacle?. Acta Anaesthesiol Scand. 47:639-642.
  • Kövesi T; Royston D; Yacoub M; Marczin N. (May 2003). Basal and nitroglycerin-induced exhaled nitric oxide before and after cardiac surgery with cardiopulmonary bypass. Br J Anaesth. 90:608-616.
  • Yacoub MH; Marczin N. (Apr 2003). Overview. CORONARY ARTERY DIS. 14:99-99. DOI.
  • Marczin N; Bundy RE; Hoare GS; Yacoub M. (Apr 2003). Redox regulation following cardiac ischemia and reperfusion. Coron Artery Dis. 14:123-133. DOI.
  • Marczin N; Kövesi T; Royston D. (Jan 2003). Exhaled nitric oxide as a marker of lung injury in coronary artery bypass surgery. Br J Anaesth. 90:101-104.
  • Al-Ruzzeh S; Hoare G; Marczin N; Asimakopoulos G; George S; Taylor K; Amrani M. (2003). Off-pump coronary artery bypass surgery is associated with reduced neutrophil activation as measured by the expression of CD11b: a prospective randomized study. Heart Surg Forum. 6:89-93.
  • Royston D; Kovesi T; Marczin N. (Jan 2003). The unwanted response to cardiac surgery: time for a reappraisal?. J Thorac Cardiovasc Surg. 125:32-35. DOI.
  • Kövesi T; Royston D; Yacoub M; Röth E; Marczin N. (20 Oct 2002). [Changes of exhaled nitrogen-monoxide concentration in acute ischemia-reperfusion injury of the lung]. Orv Hetil. 143:2393-2398.
  • Hoare GS; Chester AH; Yacoub MH; Marczin N. (Jan 2002). Regulation of NF-kappaB and ICAM-1 expression in human airway epithelial cells. Int J Mol Med. 9:35-44.
  • Hoare GS; Birks EJ; Bowles C; Banner NR; Marczin N; Yacoub MH. (23 Oct 2001). Dissociation between TNF alpha concentrations and net pro-inflammatory bioactivity in serum from patients requiring left ventricular assist device (LVAD) support. CIRCULATION. 104:555-555.
  • Marczin N; Royston D. (Aug 2001). Nitric oxide as mediator, marker and modulator of microvascular damage in ARDS. Br J Anaesth. 87:179-183.
  • Marczin N; Royston D; Yacoub M. (Dec 2000). Pro: lung transplantation should be routinely performed with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 14:739-745. DOI.
  • Bundy RE; Marczin N; Chester AH; Yacoub M. (Apr 2000). A redox-based mechanism for nitric oxide-induced inhibition of DNA synthesis in human vascular smooth muscle cells. Br J Pharmacol. 129:1513-1521. DOI.
  • Bundy RE; Marczin N; Birks EF; Chester AH; Yacoub MH. (Feb 2000). Transplant atherosclerosis: role of phenotypic modulation of vascular smooth muscle by nitric oxide. Gen Pharmacol. 34:73-84.
  • Bundy R; Marczin N; Chester AH; Yacoub M. (Nov 1999). Differential regulation of DNA synthesis by nitric oxide and hydroxyurea in vascular smooth muscle cells. Am J Physiol. 277:H1799-H1807.
  • Hoare GS; Marczin N; Chester AH; Yacoub MH. (Nov 1999). Role of oxidant stress in cytokine-induced activation of NF-kappaB in human aortic smooth muscle cells. Am J Physiol. 277:H1975-H1984.
  • Marczin N; Yacoub M. (Mar 1999). Endogenous and nitrovasodilator-induced release of nitric oxide in the airways of end stage cystic fibrosis patients. AM J RESP CRIT CARE. 159:A683-A683.
  • Bundy RE; Marczin N; Morrison K; Chester AH; Yacoub M. (Mar 1999). Influence of nitric oxide (NO) on relaxation, cell cycle and apoptosis in human vascular smooth muscle cells (HVSMC). AM J RESP CRIT CARE. 159:A345-A345.
  • Riedel B; Gal J; Hoare G; Marczin N; Royston D. (Sep 1998). Fructose-1,6-diphosphate (FDP) enhances human vascular cGMP production. ANESTHESIOLOGY. 89:U439-U439.
  • Marczin N; Gal J; Yacoub M. (Sep 1998). Influence of breath-holding and one-lung ventilation on gas phase nitric oxide (NO) levels in patients undergoing cardio-thoracic surgery. ANESTHESIOLOGY. 89:U1055-U1055.
  • Marczin N; Riedel B; Royston D; Yacoub M. (1 Aug 1998). Exhaled nitric oxide and pulmonary response to iloprost in systemic sclerosis. LANCET. 352:405-406.
  • Bundy RE; Marczin N; Chester AH; Yacoub M. (20 Mar 1998). Redox regulation of S-nitrosoglutathione (GSNO)-induced inhibition of S phase progression in human aortic smooth muscle cells (HASM). FASEB J. 12:A948-A948.
  • Marczin N; Chen X; Catravas JD; Yacoub M. (17 Mar 1998). Reduced nitric oxide (NO) release is a sensitive marker of lung cell damage in vitro and in lung transplant recipients. FASEB J. 12:A490-A490.
  • Marczin N; Riedel B; Gal J; Polak J; Yacoub M. (6 Dec 1997). Exhaled nitric oxide during lung transplantation. Lancet. 350:1681-1682. DOI.
  • Marczin N; Riedel B; Royston D; Yacoub M. (14 Jun 1997). Intravenous nitrate vasodilators and exhaled nitric oxide. LANCET. 349:1742-1742.

Books

  • Marczin N; Kharitonov SA; Yacoub MH; Barnes PJ. Marczin N (ed); Kharitonov SA (ed); Yacoub MH (ed); BArnes PJ (ed). Disease markers in exhaled breath. 170:1-560. Marcel Dekker, Inc, New York, Basel (2002).
  • N Marczin. Marczin N (ed); Yacoub MH (ed). Disease Markers in Exhaled Breath: Basic Mechanisms and Clinical Applications. NATO Science Series, 346. IOS Press, Amsterdam, Berlin, Oxford, Tokyo, Washington DC (2002).

Conferences

  • Boshier PR; Mistry V; Cushnir JR; Curtis S; Elkin S; Kon OM; Marczin N; Hanna GB. ANALYSIS OF VOLATILE BIOMARKERS WITHIN EXHALED BREATH FOR THE DIAGNOSIS OF PNEUMONIA. 65:A58-A59. (Dec 2010). DOI.
  • Kovacs V; Balatonyi B; Ghosh S; Takacs I; Horvath S; Javor S; Marczin N; Weber G; et alRoth E; Gasz B. Effect of oxidative stress of Glutathione S-tranferase in cardiomyocyte cell culture. 97:S96-S97. (Jun 2010).
  • Balatonyi B; Kovacs V; Takacs I; Horvath S; Javor S; Weber G; Marczin N; Gasz B; et alRoth E. Role of Glutathione S-tranferase in the signal pathways in cardiac myocytes under oxidative stress conditions. 97:S96-S96. (Jun 2010).
  • Fletcher M; Boshier P; Smolenski RT; Kirkham PA; Keun H; Hanna G; Takata M; Marczin N. MOLECULAR MECHANISMS OF LUNG EPITHELIAL CELL INJURY INDUCED BY INHIBITION OF GLUTATHIONE-S-TRANSFERASE. 64:A38-A39. (Dec 2009). DOI.
  • Fletcher M; Takata M; Marczin N. INHIBITORS OF GLUTATHIONE-S-TRANSFERASE INDUCE CELL DEATH IN LUNG EPITHELIAL CELLS. 63:A144-A144. (Dec 2008).
  • Bertok S; Wilson MR; Dokpesi J; O'Dea KP; Marczin N; Takata M. ROLE OF TUMOUR NECROSIS FACTOR a RECEPTOR SUBTYPES IN TUMOUR NECROSIS FACTOR-INDUCED MOUSE LUNG MICROVASCULAR ENDOTHELIAL CELL ACTIVATION. 63:A141-A141. (Dec 2008).
  • Farkasfalvi K; Stagg MA; Siedlecka U; Lee J; Soppa GK; Marczin N; Szokodi I; Yacoub MH; et alTerracciano CM. Apelin, the ligand for the angiotensin receptor-like 1, directly affects cardiomyocyte contractility and electrophysiology. 114:300-300. (31 Oct 2006).
  • Farkasfalvi K; Felkin L; Latif N; Soppa GK; George R; Birks E; Barton P; Marczin N; et alYacoub MH; Terracciano CM. The apelin receptor mRNA levels and myocardial recovery in end-stage heart failure patients treated with left ventricular assist devices (LVADs). 114:484-484. (31 Oct 2006).
  • Farkasfalvi K; Stagg MA; Siedlecka U; Lee J; Soppa GKR; Marczin N; Terracciano CMN. Direct effects of apelin, the ligand for the angiotensin receptor-like 1, on cardiomyocyte contractility and electrophysiology. World Congress of Cardiology. 27:407-407. (Aug 2006).
  • Felkin LE; Farkasfalvi K; Soppa GKR; Birks E; Marczin N; Barton PJR; Yacoub MH; Terracciano CMN. The apelin-angiotensin receptor-like 1 (APJ) mRNA levels closely correlate with myocardial recovery in end-stage heart failure patients treated with left ventricular assist devices (LVADs). 27:267-267. (Aug 2006).
  • Farkasfalvi K; Stagg MA; Siedlecka U; Lee J; Soppa GKR; Marczin N; Terracciano CMN. Direct effects of apelin, the ligand for the angiotensin receptor-like 1, on cardiomyocyte contractility and electrophysiology. 28th Annual International-Society-for-Heart-Research North American Section Meeting. 40:980-980. (Jun 2006).
  • Szabo A; Kovesi T; Gal J; Royston D; Marczin N. Diagnostic aspects of exhaled nitric oxide in cardiothoracic anaesthesia. 171-202. (2005).
  • Hoare GS; Al-Ruzzeh S; Asimakopoulos G; Taylor KM; Amrani M; Marczin N. Off-pump and on-pump coronary surgery exhibit a similar anti-inflammatory cytokine profile. American-Heart-Association Abstracts From Scientific Sessions. 106:344-344. (5 Nov 2002).
  • Marczin N. Exhaled carbon monoxide is delivered from systemic sources. 346:88-92. (2002).
  • Marczin N. Exhaled nitric oxide (NO) in human lung ischemia-reperfusion (I/R). Conference of the NATO-Advanced-Study-Institute on Disease Markers in Exhaled Breath. 346:291-299. (2002).
  • Wright IG; Marczin N. Mechanisms of and clinical efforts to minimise perioperative lung injury. Conference of the NATO-Advanced-Study-Institute on Disease Markers in Exhaled Breath. 346:274-283. (2002).
  • Adcock IM; Ito K. Molecular mechanisms of steroid actions. 346:151-158. (2002).
  • N Marczin. NATO Advanced Study Institute: DIsease Markers in Exhaled Breath. Disease Markers in Exhaled Breath, 22 Jun 2001 - 1 Jul 2001. IOS Press (2002).
  • Marczin N. NO and oxidant stress in human lung ischemia-reperfusion (I/R). 69-74. (2002).
  • Kovesi T; Bundy R; Hoare G; Royston D; Marczin N. Oxidative stress during cardiac surgery in diabetic patients. 346:375-379. (2002).
  • Marczin N; Kovesi T; Royston D; Yacoub M. Exhaled nitric oxide (NO) in acute lung injury: Measurements and physiological implications. 336:186-196. (2001).
  • Bundy RE; Yacoub M; Marczin N. Redox signalling in human vascular cells: Is there an antioxidant stress?. 336:169-173. (2001).
  • Marczin N; Riedel B; Royston D; Yacoub M. Exhaled nitric oxide in patients undergoing cardiothoracic surgery: A new diagnostic tool?. NATO Advanced Study Institute on Acute Respiratory Distress Syndrome - Cellular and Molecular Mechanisms and Clinical Management. 297:365-374. (1998).
Share this on DeliciousTweet thisDigg thisStumble thisShare this on Facebook